• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2018.13044

Anemia in rheumatoid arthritis: correlation with hepcidin and adhesion molecules

[Internal diseases]
Alexandr Yagoda; Vijaya Sarithala; Pavel Koroy;

The content of adhesion molecules and hepcidin in the blood was studied in 134 patients with rheumatoid arthritis in connection with the presence of anemia. Anemia developed in 35.8 % of patients: in 64.6 % of cases there was anemia of a chronic disease, in 35.4 % of patients – iron deficiency. In cases of anemia, the serum hepcidin concentration was higher, and the adhesion molecule parameters did not differ from those in RA patients with normal hemoglobin levels in the blood. The values of hepcidin negatively correlated with the values of hemoglobin and erythrocytes. In patients with anemia of chronic disease, unlike cases of iron deficiency anemia, significantly higher levels of hepcidin and ICAM-1 and an increased P-selectin content in the blood were noted.

Download

References:
1. Abdel-Khalek M. A., El-Barbary A. M., Essa S. A., Ghobashi A. S. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J. Rheumatol. 2011;38(10):2153-2159. https://doi.org/10.3899/jrheum.110339
2. Ateş A., Kinikli G., Turgay M., Duman M. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand. J. Immunol. 2004;59(3):315- 320. https://doi.org/10.1111/j.0300-9475.2004.01389.x
3. Cangemi G., Pistorio A., Miano M., Gattorno M., Acquila M., Bicocchi M. P., Gastaldi R., Riccardi F., Gatti C., Fioredda F., Calvillo M., Melioli G., Martini A., Dufour C. Diagnostic potential of hepcidin testing in pediatrics. Eur. J. Haematol. 2013;90:323-330. https://doi.org/10.1111/ejh.12081
4. Cheng P. P., Jiao X. Y., Wang X. H., Lin J. H., Cai Y. M. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin. Exp. Med. 2011;11(1):33-42. https://doi.org/10.1007/s10238-010-0102-9
5. Demirag M. D., Haznedaroglu S., Sancak B., Konca C., Gulbahar O., Ozturk M. A., Goker B. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Inter Med. 2009;48:421-426. https://doi.org/10.2169/internalmedicine.48.1578
6. Dessein P. H., Joffe B. I., Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res.Ther. 2005;7(3):R634-643. https://doi.org/10.1186/ar1717
7. Dkhil A. S., Hussain F., Muttar A. A. Association between interleukin-6 (IL-6) and thrombocytosis in rheumatoid arthritis patients. Inter. J. Pharm. Tech. Res. 2016;9(4): 307-312.
8. Finberg K. E. Regulation of systemic iron homeostasis. Curr. Opin. Hematol. 2013;20(3):208-214. https://doi.org/10.1097/MOH. 0b013e32835f5a47
9. Jones G., Sebba A., Gu J., Lowenstein M. B., Calvo A., Gomez-Reino J. J., Siri D. A., Tomsic M., Alecock E., Woodworth T., Genovese M. C. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann. Rheum. Dis. 2010;69(1):88-96. https://doi.org/10.1136/ard.2008.105197
10. Klimek E., Skalska A., Kwaśny-Krochin B., Surdacki A., Sulicka J., Korkosz M., Fedak D., Kierzkowska I., Wizner B., Grodzicki T. K. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm. 2014;2014:681635. https//doi:org/10.1155/2014/681635
11. Kolahi S., Ghorbanihaghjo A., Gharehgeshlaghi Jangi G. Evaluation of serum hepcidin levels and its relation to inflammatory acute-phase proteins and disease progress in patients with rheumatoid arthritis. ZUMS J. 2011;19:25-36.
12. Koroy P. V., Sarithala V. D., Yagoda A. V. Soluble molecules of immunoglobulins superfamily in rheumatoid arthritis. Medical News of North Caucasus. 2017;12(3):256-260. https://doi.org/10.14300/mnnc.2017.12092
13. Manolov V., Paskaleva-Peycheva V., Velizarova M., Atanasova B., Hadjidekova S., Vasilev V., Tzatchev K., Marinov B., Bogov I., Genchev G., Emilova R. Correlation between DAS28 and serum hepcidin levels in patients with anemia and rheumatoid arthritis. IJSR. 2015;4(1): 859-861.
14. Masson C. Rheumatoid anemia. Joint Bone Spine. 2011;78(2):131-137. https://doi.org/10.1016/j.jbspin.2010.05.017
15. Matar M. M., Elgendy H. I., Sabry R. M., Elhameed S. A. The role of hepcidin in anemia of chronic disease associated with rheumatoid arthritis. Med. J. Cairo Univ. 2010;78(2):57-62.
16. Osman K. S., Aly L. H., El-Hamid W. M. A., Tawfik M. R. Role of hepcidin in the pathogenesis of anemia not caused by iron deficiency. J. Clin. Cell. Immunol. 2014;5:193. https://doi.org/10.4172/2155-9899.1000193
17. Padjen I., Öhler L., Studenic P., Woodworth T., Smolen J., Aletaha D. Clinical meaning and implications of serum hemoglobin levels in patients with rheumatoid arthritis. Semin.Arthritis Rheum.2017;47(2):193-198. https://doi.org/10.1016/j.semarthrit.2017.03.001
18. Sabau A., Valeanu M., Bolosiu H. D., Craciun A. M. Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity. Romanian Rev. Lab. Med. 2013;21(1): 17-27. https://doi.org/10.2478/rrlm-2013-0014
19. Smyrnova G. The prevalence of anemia in rheumatoid arthritis. Rev. Bras. Reumatol. 2014;54(4):257-259. https://doi.org/10.1016/j.rbr.2014.03.023
20. Song S.-N. J., Iwahashi M., Tomosugi N., Uno K., Yamana J., Yamana S., Isobe T., Ito H., Kawabata H., Yoshizaki K. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Res.Ther. 2013;15(5):R141. https://doi.org/10.1186/ar4323
21. Suzuki S., Nakano S., Ando S., Matsudaira R., Kanai Y., Yamanaka K., Takasaki Y. Hepcidin-25 gives an indication of the therapeutic effectiveness of tocilizumab in rheumatoid arthritis – relationship between disease activity of rheumatoid arthritis and anemia. Rev. Bras. Reumatol. 2017;57(6):637-640. https://doi.org/10.1016/j.rbr.2016.07.004
22. Teke H. U., Cansu D. U., Yildiz P., Temiz G., Bal C. Clinical significance of serum IL-6, TNF-α, Hepcidin, and EPO levels in anaemia of chronic disease and iron deficiency anaemia: The laboratory indicators for anaemia. Biomedical. Research. 2017;28(6):2704-2710.
23. Thomas C., Kobold U., Balan S., Roeddiger R., Thomas L. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int. J. Lab. Hematol. 2011;33(2):187-193. https:// doi.org/10.1111/j.1751-553X.2010.01265.x
24. van Santen S., van Dongen-Lases E. C., de Vegt F., Laarakkers C. M. M., van Riel P. L. C. M., van Ede A. E., Swinkels D. W. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011;63(12):3672-3680. https://doi.org/10.1002/art.30623
25. Kebapcilar L., Erdur E., Bozkaya G., Sari I., Alacacioglu A., Kebapcilar A. G., Sop G. The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. Biol. Trace Elem. Res. 2010;137(3):317-323. https://doi.org/10.1007/s12011-009-8585-5

Keywords: rheumatoid arthritis, anemia, hepcidin, adhesion molecules